File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.biocel.2006.02.002
- Scopus: eid_2-s2.0-33646192904
- PMID: 16546434
- WOS: WOS:000238822600016
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Involvement of protein kinase C and E2F-5 in euxanthone-induced neurite differentiation of neuroblastoma
Title | Involvement of protein kinase C and E2F-5 in euxanthone-induced neurite differentiation of neuroblastoma |
---|---|
Authors | |
Keywords | Differentiation E2F-5 transcription factor Euxanthone Neurite outgrowth Neuroblastoma |
Issue Date | 2006 |
Publisher | Pergamon. The Journal's web site is located at http://www.elsevier.com/locate/biocel |
Citation | International Journal Of Biochemistry And Cell Biology, 2006, v. 38 n. 8, p. 1393-1401 How to Cite? |
Abstract | Euxanthone, a neuritogenic agent isolated from the medicinal herb Polygala caudata, has been shown to induce morphological differentiation and neurite outgrowth in murine neuroblastoma Neuro 2a cells (BU-1 subclone). In order to elucidate the underlying mechanisms of euxanthone-induced neurite outgrowth, a proteomic approach was employed. In the present study, two dimensional (2-D) gel electrophoresis and matrix-assisted laser desorption/ionization-time of flight (MALDI-ToF) mass spectrometry were performed to investigate the alterations in protein expression profile of euxanthone-treated BU-1 cells. Fourteen identified proteins were changed in expression levels after induction of neurite growth. These proteins included participants in transcription and cell cycle regulation, calcium influx and calcium signaling, fatty acid metabolism, cytoskeleton reorganization, casein kinase signal transduction, putative transbilayer amphipath transport and protein biosynthesis. Among the 14 identified proteins, E2F transcription factor 5 (E2F-5) was significantly up-regulated after euxanthone treatment. Go6976, a protein kinase C (PKC) α/βI inhibitor, was found to inhibit neuritogenesis and expression of E2F-5 in the euxanthone-treated BU-1 cells, while SH-6, the Akt/PKB inhibitor, had no inhibitory effect. The gene silencing of E2F-5 by small interfering RNA (siRNA) was found to abolish the euxanthone-induced neurite outgrowth. In conclusion, these results indicated that the transcription factor E2F-5 was actively involved in the regulation of euxanthone-induced neurite outgrowth via PKC pathway. © 2006 Elsevier Ltd. All rights reserved. |
Persistent Identifier | http://hdl.handle.net/10722/169846 |
ISSN | 2023 Impact Factor: 3.4 2023 SCImago Journal Rankings: 1.079 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ha, WY | en_HK |
dc.contributor.author | Wu, PK | en_HK |
dc.contributor.author | Kok, TW | en_HK |
dc.contributor.author | Leung, KW | en_HK |
dc.contributor.author | Mak, NK | en_HK |
dc.contributor.author | Yue, PYK | en_HK |
dc.contributor.author | Ngai, SM | en_HK |
dc.contributor.author | Tsai, SN | en_HK |
dc.contributor.author | Wong, RNS | en_HK |
dc.date.accessioned | 2012-10-25T04:57:01Z | - |
dc.date.available | 2012-10-25T04:57:01Z | - |
dc.date.issued | 2006 | en_HK |
dc.identifier.citation | International Journal Of Biochemistry And Cell Biology, 2006, v. 38 n. 8, p. 1393-1401 | en_HK |
dc.identifier.issn | 1357-2725 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/169846 | - |
dc.description.abstract | Euxanthone, a neuritogenic agent isolated from the medicinal herb Polygala caudata, has been shown to induce morphological differentiation and neurite outgrowth in murine neuroblastoma Neuro 2a cells (BU-1 subclone). In order to elucidate the underlying mechanisms of euxanthone-induced neurite outgrowth, a proteomic approach was employed. In the present study, two dimensional (2-D) gel electrophoresis and matrix-assisted laser desorption/ionization-time of flight (MALDI-ToF) mass spectrometry were performed to investigate the alterations in protein expression profile of euxanthone-treated BU-1 cells. Fourteen identified proteins were changed in expression levels after induction of neurite growth. These proteins included participants in transcription and cell cycle regulation, calcium influx and calcium signaling, fatty acid metabolism, cytoskeleton reorganization, casein kinase signal transduction, putative transbilayer amphipath transport and protein biosynthesis. Among the 14 identified proteins, E2F transcription factor 5 (E2F-5) was significantly up-regulated after euxanthone treatment. Go6976, a protein kinase C (PKC) α/βI inhibitor, was found to inhibit neuritogenesis and expression of E2F-5 in the euxanthone-treated BU-1 cells, while SH-6, the Akt/PKB inhibitor, had no inhibitory effect. The gene silencing of E2F-5 by small interfering RNA (siRNA) was found to abolish the euxanthone-induced neurite outgrowth. In conclusion, these results indicated that the transcription factor E2F-5 was actively involved in the regulation of euxanthone-induced neurite outgrowth via PKC pathway. © 2006 Elsevier Ltd. All rights reserved. | en_HK |
dc.language | eng | en_US |
dc.publisher | Pergamon. The Journal's web site is located at http://www.elsevier.com/locate/biocel | en_HK |
dc.relation.ispartof | International Journal of Biochemistry and Cell Biology | en_HK |
dc.subject | Differentiation | en_HK |
dc.subject | E2F-5 transcription factor | en_HK |
dc.subject | Euxanthone | en_HK |
dc.subject | Neurite outgrowth | en_HK |
dc.subject | Neuroblastoma | en_HK |
dc.subject.mesh | Animals | en_US |
dc.subject.mesh | Carbazoles - Pharmacology | en_US |
dc.subject.mesh | Cell Differentiation - Drug Effects | en_US |
dc.subject.mesh | Cell Line, Tumor | en_US |
dc.subject.mesh | E2f Transcription Factors - Genetics - Metabolism | en_US |
dc.subject.mesh | Electrophoresis, Gel, Two-Dimensional | en_US |
dc.subject.mesh | Gene Silencing | en_US |
dc.subject.mesh | Indoles - Pharmacology | en_US |
dc.subject.mesh | Neurites - Drug Effects - Metabolism | en_US |
dc.subject.mesh | Neuroblastoma - Metabolism - Pathology | en_US |
dc.subject.mesh | Protein Kinase C - Antagonists & Inhibitors - Metabolism | en_US |
dc.subject.mesh | Protein Kinase Inhibitors - Pharmacology | en_US |
dc.subject.mesh | Proteomics - Methods | en_US |
dc.subject.mesh | Proto-Oncogene Proteins C-Akt - Antagonists & Inhibitors - Metabolism | en_US |
dc.subject.mesh | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | en_US |
dc.subject.mesh | Xanthones - Pharmacology | en_US |
dc.title | Involvement of protein kinase C and E2F-5 in euxanthone-induced neurite differentiation of neuroblastoma | en_HK |
dc.type | Article | en_HK |
dc.identifier.email | Leung, KW: kwleung1@hku.hk | en_HK |
dc.identifier.authority | Leung, KW=rp01674 | en_HK |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1016/j.biocel.2006.02.002 | en_HK |
dc.identifier.pmid | 16546434 | - |
dc.identifier.scopus | eid_2-s2.0-33646192904 | en_HK |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-33646192904&selection=ref&src=s&origin=recordpage | en_HK |
dc.identifier.volume | 38 | en_HK |
dc.identifier.issue | 8 | en_HK |
dc.identifier.spage | 1393 | en_HK |
dc.identifier.epage | 1401 | en_HK |
dc.identifier.isi | WOS:000238822600016 | - |
dc.publisher.place | United Kingdom | en_HK |
dc.identifier.scopusauthorid | Ha, WY=7006802337 | en_HK |
dc.identifier.scopusauthorid | Wu, PK=14039819200 | en_HK |
dc.identifier.scopusauthorid | Kok, TW=8675114000 | en_HK |
dc.identifier.scopusauthorid | Leung, KW=13106059300 | en_HK |
dc.identifier.scopusauthorid | Mak, NK=35587830100 | en_HK |
dc.identifier.scopusauthorid | Yue, PYK=8570616200 | en_HK |
dc.identifier.scopusauthorid | Ngai, SM=7006074219 | en_HK |
dc.identifier.scopusauthorid | Tsai, SN=8707094300 | en_HK |
dc.identifier.scopusauthorid | Wong, RNS=7402126957 | en_HK |
dc.identifier.issnl | 1357-2725 | - |